Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry

Background: Despite an intensive multimodal treatment approach, approximately 50% of high-risk (HR) neuroblastoma (NB) patients experience progression. Despite the advances in targeted therapy, high-dose chemotherapy, and other systemic treatment options, radiation therapy (RT) to sites of relapsed...

Descripción completa

Detalles Bibliográficos
Autores principales: Jazmati, Danny, Hero, Barbara, Thole.-Kliesch, Theresa M., Merta, Julien, Deubzer, Hedwig E., Bäumer, Christian, Heinzelmann, Feline, Schleithoff, Stefanie Schulze, Koerber, Friederike, Eggert, Angelika, Schwarz, Rudolf, Simon, Thorsten, Timmermann, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689739/
https://www.ncbi.nlm.nih.gov/pubmed/36354709
http://dx.doi.org/10.3390/curroncol29110649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689739/
https://www.ncbi.nlm.nih.gov/pubmed/36354709
http://dx.doi.org/10.3390/curroncol29110649

Ejemplares similares